Editorial: The urokinase-pulmonary embolism trial.
D004357:Drug Synergism; D005343:Fibrinolytic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006470:Hemorrhage / Q000139:chemically induced; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D011655:Pulmonary Embolism / Q000188:drug therapy*; D012008:Recurrence; D012964:Sodium / Q000627:therapeutic use
D005343:Fibrinolytic Agents; D006493:Heparin; D012964:Sodium